CD133+ infusion

DRUG2 trials

Sponsors

Jozef Bartunek, Hospital San Carlos, Madrid

Conditions

Acute Myocardial InfarctionColorectal Cancer

Phase 2

Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.

CompletedNCT03803241

Hospital San Carlos, MadridColorectal Cancer

Start: 2019-05-31End: 2021-06-30Updated: 2021-09-27

Unknown Phase

A Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction

TerminatedNCT00529932

Jozef BartunekAcute Myocardial Infarction

Start: 2007-09-30End: 2012-12-31Updated: 2015-04-22

Related Papers

CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial.

2019-10-072 citations